FEATURED EDITORIAL

Cardiovascular risk prediction: are we there yet?

Rod Jackson

Correspondence to:
Professor R Jackson, Section of Epidemiology and Biostatistics, School of Population Health, Tamaki Campus, Faculty of Medical and Health Sciences, University of Auckland, 100 Morrin Rd, Glen Innes, Auckland, Private Bag 92019, Auckland, New Zealand; rt.jackson@auckland.ac.nz

The first 150 words of the full text of this article appear below.

Rod Jackson

It has been a long journey getting cardiovascular disease (CVD) risk prediction recognised as relevant to clinical decision-making. The Framingham Heart Study investigators put CVD risk prediction on the map over 30 years ago with their Framingham CVD risk scores, and Bill Kannel’s seminal 1976 paper advising clinicians to inform their risk management decisions using predicted CVD risk rather than individual risk factor levels has stood the test of time.¹ There is now a wealth of supporting evidence that major CVD risk factors like blood pressure or blood lipid levels are not only individually poor predictors of a patient’s CVD risk but also of a patient’s potential to benefit from treatment, when compared with multifactor CVD risk prediction estimates.² Disappointingly, estimating CVD risk remains the exception rather than the rule in routine clinical practice.³ As a result, CVD risk factor management is poorly targeted⁴ because risk prediction, like . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study

J Hippisley-Cox, C Coupland, Y Vinogradova, J Robson, and P Brindle
Heart 2008 94: 34-39. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Cooney, M. T., Dudina, A. L., Graham, I. M. (2009). Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.. J Am Coll Cardiol 54: 1209-1227 [Abstract] [Full Text]  
• Vasan, R. S., Kannel, W. B. (2009). Strategies for Cardiovascular Risk Assessment and Prevention Over the Life Course: Progress Amid Imperfections. Circulation 120: 360-363 [Full Text]  
• Cederholm, J., Eeg-Olofsson, K., Eliasson, B., Zethelius, B., Nilsson, P. M., Gudbjornsdottir, S., on behalf of the Swedish National Diabetes Registe, (2008). Risk Prediction of Cardiovascular Disease in Type 2 Diabetes: A risk equation from the Swedish National Diabetes Register. Diabetes Care 31: 2038-2043 [Abstract] [Full Text]